Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1964 1
1965 4
1966 3
1967 7
1968 2
1969 1
1970 2
1972 1
1973 1
1974 1
1975 1
1976 2
1977 2
1978 4
1979 3
1981 3
1982 2
1983 3
1984 1
1986 1
1989 1
1990 1
1993 1
1994 3
1995 4
1996 3
1997 2
1998 3
1999 2
2000 2
2001 4
2002 7
2003 3
2004 9
2005 7
2006 9
2007 7
2008 5
2009 5
2010 7
2011 3
2012 8
2013 8
2014 13
2015 11
2016 11
2017 15
2018 14
2019 22
2020 19
2021 26
2022 22
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Results by year

Filters applied: . Clear all
Page 1
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events.
Tsukamoto H, Komohara Y, Tomita Y, Miura Y, Motoshima T, Imamura K, Kimura T, Ikeda T, Fujiwara Y, Yano H, Kamba T, Sakagami T, Oshiumi H. Tsukamoto H, et al. Among authors: sakagami t. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2205378119. doi: 10.1073/pnas.2205378119. Epub 2022 Jul 11. Proc Natl Acad Sci U S A. 2022. PMID: 35858347 Free PMC article.
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, Hamada S, Iyama S, Saruwatari K, Saeki S, Takahashi M, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: sakagami t. Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022. Oncoimmunology. 2022. PMID: 35655708 Free PMC article.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: sakagami t. Eur J Cancer. 2021 Dec;159:144-153. doi: 10.1016/j.ejca.2021.09.041. Epub 2021 Nov 5. Eur J Cancer. 2021. PMID: 34749119
Evolution of asthma treatment goals.
Sakagami T. Sakagami T. Respir Investig. 2023 May;61(3):333-334. doi: 10.1016/j.resinv.2023.02.003. Epub 2023 Mar 15. Respir Investig. 2023. PMID: 36931093 No abstract available.
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.
Tanaka K, Chamoto K, Saeki S, Hatae R, Ikematsu Y, Sakai K, Ando N, Sonomura K, Kojima S, Taketsuna M, Kim YH, Yoshida H, Ozasa H, Sakamori Y, Hirano T, Matsuda F, Hirai T, Nishio K, Sakagami T, Fukushima M, Nakanishi Y, Honjo T, Okamoto I. Tanaka K, et al. Among authors: sakagami t. Sci Transl Med. 2022 Dec 14;14(675):eabq0021. doi: 10.1126/scitranslmed.abq0021. Epub 2022 Dec 14. Sci Transl Med. 2022. PMID: 36516270
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Tazawa R, et al. Among authors: sakagami t. N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
[Prostaglandins].
Sakagami T. Sakagami T. Tanpakushitsu Kakusan Koso. 1967 Feb;12(2):135-44. Tanpakushitsu Kakusan Koso. 1967. PMID: 4863359 Review. Japanese. No abstract available.
Occupational Lung Disease Caused by Exposure to Polytetrafluoroethylene.
Aoki A, Saito A, Shima K, Kimura Y, Asakawa K, Ohashi R, Umezu H, Sakagami T, Moriyama H, Kikuchi T. Aoki A, et al. Among authors: sakagami t. Intern Med. 2022 Dec 15;61(24):3713-3717. doi: 10.2169/internalmedicine.9008-21. Epub 2022 May 21. Intern Med. 2022. PMID: 35598992 Free PMC article.
303 results